Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study.

Publikation

Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study.

Wissenschaftlicher Artikel/Review - 12.05.2023

Yurttas Timur, Djurdjevic Mirjana, Schnider Thomas, Filipovic Miodrag

Zitation

Yurttas T, Djurdjevic M, Schnider T, Filipovic M. Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blinded, placebo-controlled, single centre study. Br J Anaesth 2023

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Br J Anaesth 2023

Veröffentlichungsdatum

12.05.2023

eISSN (Online)

1471-6771

Kurzbeschreibung/Zielsetzung

Intravenous lidocaine is used as an adjuvant analgesic agent in perioperative settings. It has been investigated in various patient populations and surgical interventions, but there are limited data on its efficacy, particularly for patients undergoing bariatric surgery. Obese patients are at high risk of postoperative respiratory complications and can be expected to benefit from anaesthetic techniques that minimise opioid administration.